Navigation Links
iCAD To Release Fourth Quarter and Year End 2007 Financial Results on Thursday, March 6, 2008

NASHUA, N.H., Feb. 11 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that the Company's fourth quarter and year end 2007 financial results will be announced before market open on Thursday, March 6, 2008. iCAD management will discuss the results during a conference call scheduled for 10:00 am ET.

Shareholders and other interested parties may participate in the conference call by dialing +1-888-713-4213 (domestic) or +1-617-213-4865 (international) and entering passcode 94453837 a few minutes before 10:00 am ET on Thursday, March 6, 2008. The call will also be broadcast live on the Internet at, or

A replay of the conference call will be accessible 2 hours after its completion through March 13, 2008 by dialing +1- 888-286-8010 (domestic) or +1-617-801-6888 (international) and entering passcode 65836264. The call will also be archived for 90 days at, and

About iCAD, Inc.

iCAD, Inc. (Nasdaq: ICAD) is an industry-leading provider of Computer- Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over 1800 women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit

For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at

For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 or via email at

For iCAD Public Relations, contact Wendy Ryan of Schwartz Communications at 781-684-0770 or via email at

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995:

Certain statements contained in this News Release constitute "forward- looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve a number of known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. Such factors include, but are not limited to, the risks of uncertainty of patent protection, the impact of supply and manufacturing constraints or difficulties, product market acceptance, possible technological obsolescence, increased competition, customer concentration and other risks detailed in the Company's filings with the Securities and Exchange Commission. The words "believe", "demonstrate", "intend", "expect", "estimate", "anticipate", "likely", and similar expressions identify forward- looking statements. Readers are cautioned not to place undue reliance on those forward-looking statements, which speak only as of the date the statement was made. The Company is under no obligation to provide any updates to any information contained in this release.

Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Pennsylvania DEP Releases 4th Quarter 2007 Mammography Inspection Results
2. NHP Announces Fourth Quarter Earnings Release Date and Conference Call/Webcast
3. Merit Medical Systems Announces Earnings Release Date/Time and Conference Call Information for the Year Ended December 31, 2007
4. NHS Choices Releases New Health A-Z Index
5. Lupus Foundation of America Releases New Patient Education Series
6. SfN releases Best Practices for Protecting Researchers and Research
7. HLTH and WebMD Announce Fourth Quarter Earnings Release Date and Conference Call
8. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
9. American Pacific to Release Financial Results and Hold Fiscal 2008 First Quarter Investor Teleconference
10. Webcast Alert: Oscient Pharmaceuticals Announces Date for Release of Fourth Quarter Financial Results
11. Horace Mann Announces Fourth Quarter Earnings Release and Conference Call
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... According to Los ... people to overeat are not necessarily caused by real hunger, but instead by ... needs food. He notes that, while many patients are aware that weight loss surgery ...
(Date:11/30/2015)... ... November 30, 2015 , ... A record crowd gathered at the ... organized by the Baruch S. Blumberg Institute. , The institute, which is the research ... science and biotechnology leaders for the conference, which focused on ways companies can work ...
(Date:11/30/2015)... ... November 30, 2015 , ... A novel class of antimicrobials ... effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of the major drug-resistant bacterial ... small molecule analogs that target the functions of SecA, a central part of ...
(Date:11/30/2015)... NJ (PRWEB) , ... November 30, 2015 , ... ... top choice for innovative, patient centered orthopedic care. Led by John Vitolo, ... your injury or chronic condition, the team at Advocare Orthopedic & Sports Medicine ...
(Date:11/30/2015)... (PRWEB) , ... November 30, 2015 , ... ... specializes in general dentistry out of Glen Ridge, NJ. He has both ... to achieve optimal mastication. He is also an expert in cosmetic dentistry. ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Diplomat Pharmacy, Inc. (NYSE: ... the Detroit Free Press as a Top Workplace , ... to work for in 2015. ... 100 winners annually, based on employee surveys rating company leadership, ... Workplaces are based solely on employee feedback. The survey is ...
(Date:11/30/2015)... , Nov. 30, 2015  IBA Molecular North America, ... distribution of radiopharmaceuticals, announced that as of January 1, ... (Zevacor Pharma). The decision to rebrand the company reflects ... as well as its close relationship with Zevacor Molecular.  ... Health and Science (IHS). Peter Burke ...
(Date:11/30/2015)... 30, 2015 Baxalta Incorporated (NYSE: ... dedicated to delivering transformative therapies to patients ... today announced the launch and first shipments ... extended circulating half-life recombinant factor VIII (rFVIII) ... ADVATE [Antihemophilic Factor (Recombinant)]. The treatment was ...
Breaking Medicine Technology: